Patent applications published 15 December 2010

Published: 14-Jan-2011

Selected patent applications from the weekly European Patents Bulletin


  • Pharmaceutical compsns of a combination of metformin and a dipeptidyl peptidase-IV inhibitor
    Merck Sharp & Dohme 2259676*

  • Systemic purine administration: modulating axonal outgrowth of central nervous system neurons
    Alseres Pharmaceuticals 2259677*

  • Protein kinase modulators
    Cylene Pharmaceuticals 2259678*

  • Methods for treatment of kallikrein-related disorders
    Joslin Diabetes Centre; Activesite Pharmaceuticals 2259679*

  • Soluble epoxide hydrolase inhibitors, compsns containing such compounds and methods of treatment
    Merck Sharp & Dohme 2259680*

  • Dual pharmacophores-PDE4-muscarinic antagonists
    Glaxo Group 2259681*

  • Improving enzymatic treatment of a proteinaceous substrate by enzymatic removal of free thiols
    Danisco 2259682*

  • CCR5 antagonists as prophylactics for preventing HIV infection and methods for inhibiting transmission of same
    Schering 2259772*

  • Macrolide compsns having improved taste and stability
    PARI Pharma 2259773*

  • Methods and compsns for delivering interleukin-1 receptor antagonist
    Biomet Biologics 2259774*

  • System for delivery of protein in insoluble fibrillar or aggregate form
    Ramot at Tel Aviv University 2259775*

  • Topotecan ready to use solutions
    Eagle Pharmaceuticals; Scidose 2259776*

  • Pharmaceutical compsn for poorly soluble drugs
    BIAL - Portela & Ca 2259777*

  • Mixture for producing rapidly disintegrating tablets
    Südzucker Aktiengesellschaft Mannheim/Ochsunfurt 2259778*

  • Improved isomalt-containing tablets and methods for the production thereof
    Südzucker Aktiengesellschaft Mannheim/Ochsunfurt 2259779*

  • Pharmaceutical compsn comprising naltrexone
    Syntropharma 2259780*

  • Process for preparing a pharmaceutical compsn with anti-inflammatory and analgesic activity for administration via a patch for external use, and compsn thus obtained
    Altergon 2259781*

  • Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
    Grant, Ross Stewart; Braidy, Nady; Guillermin, Gilles; Smythe, George 2259782*

  • 3-(2-dimethylaminomethyl-cyclo-hexyl)-phenol against polyneuropathic pain
    Grünenthal 2259783*

  • Compsn and method for irrigation of a prepared dental root canal
    The University of British Columbia 2259784*

  • Fullerene therapies for inflammation
    Luna Innovations 2259785*

  • Method for inhibiting the build-up of arterial plaque by administering fullerenes
    Luna Innovations 2259786*

  • IKKI inhibitor therapies and screening methods, and related IKKI diagnostics
    The Regents of the University of Michigan 2259787*

  • Treatment of bladder diseases with a TLR7 activator
    The Regents of the University of California; Telormedix 2259788*

  • Pharmaceutical kit consisting of an oil-in-water emulsion and a solid compsn
    Neopharmacie 2259789*

  • ABCA-1 elevating compounds and the use thereof
    Gilead Palo Alto 2259790*

  • GLP-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
    Tel HaShomer Medical Research Infrastructure and Services 2259791*

  • Methods for treating and preventing brain tumours based on bone morphogenic proteins
    DKFZ Deutsches Krebsforschungszentrum 2259792*

  • Use of corticotropin-releasing factor for the treatment of cancer
    Neutron Row 2259793*

  • Method for treatment of photosensitivity and phototoxicity
    Clinuvel Pharmaceuticals 2259794*

  • Anti-VEGF antibody
    Epitomics 2259795*

  • Materials and methods for improved immunoglycoproteins
    Trubion Pharmaceuticals 2259796*

  • Methods for preventing or treating colorectal cancer
    Schering 2259797*

  • Compsns and methods for drug delivery
    Baxter International; Baxter Healthcare; The Board of Regents of the University of Nebraska 2259798*

  • Combination of immunomodulator and anti-pathogenic agent
    Nunes, Iseu Da Silva 2259799*

  • Use of pyrimidine derivatives for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members
    Novartis 2259800*

  • Stable pharmaceutical compsns of carvedilol
    Lupin 2259801*

  • Drug fusions and conjugates
    Glaxo 2259802*

  • Device for promotion of haemostatis and/or wound healing
    Ferrosan Medical Devices 2259803*

You may also like